A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Clinical trial NCT04810676 · COMPLETED

Trial details

NCT number: NCT04810676
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2021-04-16
Primary completion: 2021-05-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.